NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
J0175 Injection, donanemab-azbt, 2 mg HCPCS · Treatment
Classification Treatment Injections and Infusions (nononcologic) Injection - Monoclonal Antibodies (CMS RBCS)
First observed 2024
National scale 901,269 services · est. · 505 FFS beneficiaries (CY2024, all-Medicare estimate) — 449,525 observed fee-for-service services
Medicare paid $2.9M · est. · $3.21 avg / service, national — $1.4M observed FFS
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Estimated all-Medicare volume estimate
FFS + estimated MA

~901,269 services

449,525 observed fee-for-service (50%) · ~451,744 estimated Medicare Advantage.

Billing for this code concentrates in one state — scaled by the national payer mix (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Payments · FFS observed

$1.4M

all-Medicare ≈$2.9M — estimate; price parity assumed as well
Named groups

11

11 at the ≥11-service disclosure floor
Top states — J0175 (CY2024)

Est. all-Medicare services by billing state (scaled estimate — assumes MA utilization mirrors FFS); open a bar for that state's ranked market.

What they charge

Half the field lists between $9 and $13

Submitted charges are provider-set list amounts, not payments · median $10 (named groups)
National benchmarkspremium

Computed for this market — a Platform view

Market positionpremium

Computed for this market — a Platform view

The whole field, one canvaspremium

Computed for this market — a Platform view

See it in full: nuclear heart imaging (78452) in Arizona is open as a live example — every paid panel, on real data.

View the live example →
Refine: group size any 5+ locked column25+ locked column100+ locked column independent only locked column
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column

sorts locked on the free tier · services rank pinned · refine and export are Platform features

1
TAMPA · FL · NURSE PRACTITIONER · 43 providers · hospital-affiliated · (813) 775-9997
35,350services 9.9%Share of state* $9avg list premiumMedicare $
2
SARASOTA · FL · DIAGNOSTIC RADIOLOGY · 187 providers · hospital-affiliated · (941) 366-1888
26,600services 7.5%Share of state* $9avg list premiumMedicare $
3
SCOTTSDALE · WI · GASTROENTEROLOGY · 2 providers · independent · (480) 927-3800
21,350services 100.0%Share of state* $11avg list premiumMedicare $
4
NORTH MIAMI BEACH · FL · ORTHOPEDIC SURGERY · 205 providers · hospital-affiliated · (305) 949-2700
14,700services 4.1%Share of state* $10avg list premiumMedicare $
5
TAMPA · FL · NURSE PRACTITIONER · 82 providers · hospital-affiliated · (813) 739-7493
11,550services 3.2%Share of state* $19avg list premiumMedicare $

You are at the seam — 5 of 11 groups named.

See the Platform — the full read, every number below, code baskets, and export. Notify me at launch →
That's the top 5 of 11 groups. The platform ranks the whole market — code baskets, benchmarks, and the full ranked list. the full ranking is part of the market analytics platform — built, not launched yet. Notify me at launch →

Medicare $ counts J0175 payments in the market each row names, CY2024; avg list is that row's submitted charges per service on the same basis — list amounts, not payments.

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix — and the observed foundation every market figure here builds on. Market totals anchor on a labeled all-Medicare estimate scaled from that foundation, with the observed count disclosed beside it — Medicare only, never all-payer. Modeled all-payer databases project every payer statistically and typically run higher. Same market, different denominator. How the numbers reconcile →